|
PC1
|
PC2
|
PC3
|
PC4
|
PC5
|
PC6
|
PC7
|
PC8
|
|---|
|
IL-15 (0.972)
|
IFNγ (0.955)
|
MMP-8 (0.849)
|
GM-CSF (0.913)
|
CXCL10 (-0.676)
|
MMP-2 (-0.700)
|
bFGF (0.744)
|
EGF (0.735)
|
|
IL-2 (0.970)
|
IL-12 (0.936)
|
MMP-9 (0.796)
|
IL-10 (0.813)
|
IL-13 (0.626)
|
MMP-3 (-0.759)
|
IL-1Ra (0.493)
|
CXCL8 (0.436)
|
|
MIP-1β (0.930)
|
IL-5 (0.842)
|
CXCL8 (0.527)
| |
VEGF (0.437)
| | |
MCP-1 (0.425)
|
|
IFNα (0.916)
|
Eotaxin (0.760)
|
HGF (0.453)
| | | | | |
|
IL-1β (0.877)
|
IL-2R (0.712)
| | | | | | |
|
TNFα (0.841)
|
IL-17 (0.633)
| | | | | | |
|
MIP-1α (0.812)
|
IL-4 (-0.565)
| | | | | | |
|
IL-7 (0.771)
|
IL-13 (0.525)
| | | | | | |
|
IL-6 (0.736)
|
MCP-1 (0.499)
| | | | | | |
|
MIG (0.722)
|
VEGF (-0.477)
| | | | | | |
|
IL-1Ra (0.680)
|
TNFα (0.408)
| | | | | | |
|
IL-17 (0.674)
| | | | | | | |
|
IL-4 (0.673)
| | | | | | | |
|
IL-2R (0.609)
| | | | | | | |
|
GCSF (0.486)
| | | | | | | |
|
HGF (0.462)
| | | | | | | |
|
30.16%a
|
17.61%a
|
6.63%a
|
6.03%a
|
4.80%a
|
3.90%a
|
4.70%a
|
4.44%a
|
- Biomarkers in each principal component are shown with factor loadings (brackets) after varimax rotation. bFGF, basic fibroblast growth factor; EGF, epidermal growth factor; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; HGF, hepatocyte growth factor; IL-1Ra, IL-1 receptor antagonist; MCP-1, monocyte chemotactic protein-1; MIG, monokine induced by gamma interferon; MIP-1, macrophage inflammatory protein-1; MMP, matrix metalloproteinase; PC, principal component; VEGF, vascular endothelial growth factor. aPercentage variance.
